Reviews on remdesivir in Covid-19 treatment
Remdesivir (GS-5734; Gilead Sciences Inc., US) is an investigational nucleoside analog that acts as a competitive inhibitor of viral RNAdependent
Category: Drug delivery
RotaChrom Technologies Partners With Cyclolab to Increase Production of COVID-19 Treatment
RotaChrom Technologies, the developer of the world’s first industrial-scale Centrifugal Partition Chromatography (CPC) technology platform, announced today the launch of
Successful use of SBECD as vehicle in intravitreal treatment
A retrospective study based on data collected from Memorial Sloan-Kettering Cancer Center, New York shows high efficacy and low toxicity
Renal and liver injury following the treatment of covid-19 by remdesivir
Remdesivir initially was intravenously administrated to treat the Ebola disease however right now it has been administered to treat COVID-19
Press Release – Development of Autophagy Inducing Cyclodextrin Derivatives for Aging-associated Diseases
CycloLab Cyclodextrin R&D Ltd. proudly announces winning of a national grant about the development of cyclodextrin-dervatives for autophagy-associated neurodegenerative diseases.
Thapsigargin repurposing for COVID-19
Whilst COVID-19 vaccines are being rolled out for mass vaccination, the modest number of antivirals in use or development for
Clinical trial for Postprandial Responses to ACD-encapsulated Hydroxytyrosol-enriched Bread
The amelioration of postprandial glucose and insulin responses to bread is of great importance since it may have significant beneficial
Hygroscopic measurements on aqueous 2-HP-b-CD droplets as aerosols for drug delivery to the lungs
Despite the interest in CDs as medicinal agents and excipients, the physiochemical properties of CDs and CD derivatives, for example
Roquette on the role of cyclodextrins in vaccines
For vaccine developers, there is intense interest in the critical role of functional excipientsin ensuring the ultimate success of their
CD-based Nanoparticles from CNR-ISMN Institute of Nanostructured Materials
The research group of CNR-ISMN Institute of Nanostructured Materials has developed various CDE-based nanoparticles, nanoassemblies for biomedical applications. Nanoassemblies based